Copyright
©The Author(s) 2022.
World J Stem Cells. Oct 26, 2022; 14(10): 744-755
Published online Oct 26, 2022. doi: 10.4252/wjsc.v14.i10.744
Published online Oct 26, 2022. doi: 10.4252/wjsc.v14.i10.744
Main conditions | NCT number | Phase |
Osteoarthritis | NCT03818737 | Phase III |
Osteoarthritis | NCT02846675, NCT02967874 | Phase II |
Knee osteoarthritis | NCT04050111 | Phase II |
Knee osteoarthritis | NCT02276833, NCT04043819, NCT03940950 | Phase I |
Phase I | ||
Osteoarthritis | NCT03166410, NCT02697682, NCT02726945 | Preclinical |
Preclinical | ||
Knee osteoarthritis | NCT04440189, NCT02726945, NCT04440189 | Preclinical |
Preclinical |
- Citation: Tang Q, Zhao XS, Guo A, Cui RT, Song HL, Qi ZY, Pan Y, Yang Y, Zhang FF, Jin L. Therapeutic applications of adipose-derived stromal vascular fractions in osteoarthritis. World J Stem Cells 2022; 14(10): 744-755
- URL: https://www.wjgnet.com/1948-0210/full/v14/i10/744.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i10.744